The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2015

Filed:

May. 17, 2011
Applicants:

Sai Reddy, Berkeley, IL (US);

Xin GE, Riverside, CA (US);

Jason Lavinder, Round Rock, TX (US);

Daniel Boutz, Austin, TX (US);

Andrew D. Ellington, Austin, TX (US);

Edward M. Marcotte, Austin, TX (US);

George Georgiou, Austin, TX (US);

Inventors:

Sai Reddy, Berkeley, IL (US);

Xin Ge, Riverside, CA (US);

Jason Lavinder, Round Rock, TX (US);

Daniel Boutz, Austin, TX (US);

Andrew D. Ellington, Austin, TX (US);

Edward M. Marcotte, Austin, TX (US);

George Georgiou, Austin, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C40B 30/04 (2006.01); C07K 16/06 (2006.01); G01N 33/68 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/065 (2013.01); C12Q 1/6881 (2013.01); G01N 33/6857 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C12Q 2600/16 (2013.01); C40B 30/04 (2013.01);
Abstract

Methods and compositions for identification of candidate antigen-specific variable regions as well as generation of antibodies or antigen-binding fragments that could have desired antigen specificity are provided. For example, in certain aspects methods for determining amino acid sequences of serum antibody CDR and abundancy level are described. In some aspects, methods for determining nucleic acid sequences of antibody variable region sequences and frequency are provided. Furthermore, the invention provides methods for identification and generation of antibody or antigen-binding fragments that comprise highly-represented CDR.


Find Patent Forward Citations

Loading…